We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+12.33%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$15.6B
AUM Growth
+$1.15B
Cap. Flow
-$252M
Cap. Flow %
-1.61%
Top 10 Hldgs %
27.58%
Holding
750
New
44
Increased
354
Reduced
220
Closed
56

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$64.3M
2
AAPL icon
Apple
AAPL
+$53M
3
CRM icon
Salesforce
CRM
+$52.8M
4
AMAT icon
Applied Materials
AMAT
+$42.9M
5
MU icon
Micron Technology
MU
+$41.3M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$68.6M
2
ADBE icon
Adobe
ADBE
+$58.8M
3
ANSS
Ansys
ANSS
+$52.1M
4
TJX icon
TJX Companies
TJX
+$39.6M
5
TMO icon
Thermo Fisher Scientific
TMO
+$38.3M

Sector Composition

Rank Sector Weight
1 Technology 31.73%
2 Healthcare 28.37%
3 Financials 8.73%
4 Consumer Discretionary 8.29%
5 Industrials 6.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LI icon
526
Li Auto
LI
$14.4B
$1.67M 0.01%
55,000
LPLA icon
527
LPL Financial
LPLA
$27B
$1.66M 0.01%
6,273
+1,087
+21% +$274K
ANSS
528
DELISTED
Ansys
ANSS
$1.66M 0.01%
4,773
-153,869
-97% -$52.1M
EXR icon
529
Extra Space Storage
EXR
$32.3B
$1.65M 0.01%
11,211
+1,356
+14% +$198K
MRO
530
DELISTED
Marathon Oil Corporation
MRO
$1.64M 0.01%
57,916
+26,617
+85% +$642K
ALGN icon
531
Align Technology
ALGN
$12.9B
$1.63M 0.01%
4,959
+2,015
+68% +$591K
LOPE icon
532
Grand Canyon Education
LOPE
$4.22B
$1.62M 0.01%
11,917
+2,614
+28% +$341K
PFG icon
533
Principal Financial Group
PFG
$24.3B
$1.62M 0.01%
18,803
+3,094
+20% +$248K
RJF icon
534
Raymond James Financial
RJF
$33.5B
$1.61M 0.01%
12,516
+799
+7% +$93.1K
COR icon
535
Cencora
COR
$62B
$1.57M 0.01%
6,477
+932
+17% +$214K
DOC icon
536
Healthpeak Properties
DOC
$15.5B
$1.56M 0.01%
83,100
+5,464
+7% +$99.3K
SQM icon
537
Sociedad Química y Minera de Chile
SQM
$19.3B
$1.55M 0.01%
+31,500
New +$1.48M
CHTR icon
538
Charter Communications
CHTR
$17.3B
$1.54M 0.01%
5,282
-26
-0.5% -$8.36K
KVUE icon
539
Kenvue
KVUE
$38B
$1.53M 0.01%
71,094
-12,077
-15% -$245K
CSGP icon
540
CoStar Group
CSGP
$12.2B
$1.51M 0.01%
15,601
+831
+6% +$71.5K
JBTM
541
JBT Marel
JBTM
$7.35B
$1.5M 0.01%
14,325
+6,474
+82% +$645K
GDDY icon
542
GoDaddy
GDDY
$13.9B
$1.48M 0.01%
12,496
-547
-4% -$60.9K
GLW icon
543
Corning
GLW
$107B
$1.47M 0.01%
44,660
+1,304
+3% +$41.5K
MPWR icon
544
Monolithic Power Systems
MPWR
$61.4B
$1.45M 0.01%
2,138
+651
+44% +$435K
WDC icon
545
Western Digital
WDC
$159B
$1.41M 0.01%
27,337
-4,194
-13% -$184K
DOW icon
546
Dow Inc
DOW
$22B
$1.41M 0.01%
24,266
DLTR icon
547
Dollar Tree
DLTR
$24.8B
$1.4M 0.01%
10,536
+1,616
+18% +$222K
AXON
548
Axon Enterprise
AXON
$42.8B
$1.38M 0.01%
4,413
SJM icon
549
J.M. Smucker
SJM
$13.5B
$1.38M 0.01%
10,969
+980
+10% +$124K
MKL icon
550
Markel Group
MKL
$25.2B
$1.38M 0.01%
906
-3
-0.3% -$4.4K

Similar funds

Candriam SCA's Q1 2024 Portfolio in Review

As of Q1 2024, Candriam SCA held 750 positions worth $15.6B, up 7.9% from $14.5B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Candriam SCA's Q1 2024 filing shows 44 new, 354 increased, 220 reduced and 56 closed positions. Its largest new stake was Altair Engineering Inc: 434,749 shares worth $37.5M. The largest sale was Merck, an estimated $68.6M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q1 2024 buy was Altair Engineering Inc: 434,749 shares worth $37.5M.
  • Candriam SCA added most to NVIDIA in Q1 2024, an estimated $64.3M increase.
  • Candriam SCA's biggest Q1 2024 reduction was Merck, cutting an estimated $68.6M.
  • Candriam SCA fully exited Immunogen Inc in Q1 2024, selling an estimated $33.3M.
  • Candriam SCA's ten largest holdings make up 28% of its $15.6B portfolio in Q1 2024.
  • Candriam SCA opened 44 new positions and closed 56 in Q1 2024.
  • Candriam SCA's portfolio value rose 7.9% quarter-over-quarter to $15.6B.

Based on Candriam SCA's 13F filing for Q1 2024, filed 6 May 2024.